Dilek Iusuf

816 total citations
16 papers, 668 citations indexed

About

Dilek Iusuf is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Dilek Iusuf has authored 16 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Pediatrics, Perinatology and Child Health and 5 papers in Molecular Biology. Recurrent topics in Dilek Iusuf's work include Drug Transport and Resistance Mechanisms (11 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Dilek Iusuf is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). Dilek Iusuf collaborates with scholars based in Netherlands, United Kingdom and Italy. Dilek Iusuf's co-authors include Alfred H. Schinkel, Jos H. Beijnen, Evita van de Steeg, Anton J.M. Roks, Wiek H. van Gilst, Robert H. Henning, Els Wagenaar, Rolf W. Sparidans, Hilde Rosing and Anita van Esch and has published in prestigious journals such as Clinical Cancer Research, Hypertension and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Dilek Iusuf

16 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dilek Iusuf Netherlands 14 343 205 125 113 99 16 668
Ji Ha Choi South Korea 17 239 0.7× 348 1.7× 100 0.8× 36 0.3× 139 1.4× 36 917
Zhousheng Xiao China 11 265 0.8× 435 2.1× 52 0.4× 54 0.5× 261 2.6× 12 986
Naoaki Murao Japan 15 161 0.5× 205 1.0× 58 0.5× 24 0.2× 56 0.6× 26 624
Masayuki Ohbayashi Japan 14 297 0.9× 224 1.1× 108 0.9× 12 0.1× 70 0.7× 34 664
Magdalena Niemira Poland 17 121 0.4× 459 2.2× 31 0.2× 31 0.3× 44 0.4× 47 828
Chengguo Wei United States 18 72 0.2× 453 2.2× 31 0.2× 35 0.3× 70 0.7× 28 1.1k
Qiong‐Yu Mi China 13 226 0.7× 441 2.2× 13 0.1× 120 1.1× 81 0.8× 31 937
Maurice G. Emery United States 16 81 0.2× 160 0.8× 39 0.3× 62 0.5× 130 1.3× 50 1.0k
Kathleen A. Hopp United States 13 83 0.2× 276 1.3× 61 0.5× 16 0.1× 125 1.3× 18 683
Joseph Jamieson United States 5 104 0.3× 308 1.5× 20 0.2× 97 0.9× 81 0.8× 6 545

Countries citing papers authored by Dilek Iusuf

Since Specialization
Citations

This map shows the geographic impact of Dilek Iusuf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dilek Iusuf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dilek Iusuf more than expected).

Fields of papers citing papers by Dilek Iusuf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dilek Iusuf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dilek Iusuf. The network helps show where Dilek Iusuf may publish in the future.

Co-authorship network of co-authors of Dilek Iusuf

This figure shows the co-authorship network connecting the top 25 collaborators of Dilek Iusuf. A scholar is included among the top collaborators of Dilek Iusuf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dilek Iusuf. Dilek Iusuf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Li, Wenlong, Dilek Iusuf, Rolf W. Sparidans, et al.. (2023). Organic anion-transporting polypeptide 2B1 knockout and humanized mice; insights into the handling of bilirubin and drugs. Pharmacological Research. 190. 106724–106724. 7 indexed citations
2.
Iusuf, Dilek, Jeroen J. M. A. Hendrikx, Anita van Esch, et al.. (2014). Human OATP1B1, OATP1B3 and OATP1A2 can mediate thein vivouptake and clearance of docetaxel. International Journal of Cancer. 136(1). 225–233. 47 indexed citations
3.
Iusuf, Dilek, Marion Ludwig, Ahmed M.O. Elbatsh, et al.. (2013). OATP1A/1B Transporters Affect Irinotecan and SN-38 Pharmacokinetics and Carboxylesterase Expression in Knockout and Humanized Transgenic Mice. Molecular Cancer Therapeutics. 13(2). 492–503. 35 indexed citations
4.
Lin, Fan, Serena Marchetti, Dick Pluim, et al.. (2013). Abcc4 Together with Abcb1 and Abcg2 Form a Robust Cooperative Drug Efflux System That Restricts the Brain Entry of Camptothecin Analogues. Clinical Cancer Research. 19(8). 2084–2095. 38 indexed citations
5.
Iusuf, Dilek, Anita van Esch, Maxine Taylor, et al.. (2013). Murine Oatp1a/1b Uptake Transporters Control Rosuvastatin Systemic Exposure Without Affecting Its Apparent Liver Exposure. Molecular Pharmacology. 83(5). 919–929. 33 indexed citations
6.
Iusuf, Dilek, Evita van de Steeg, & Alfred H. Schinkel. (2012). Hepatocyte Hopping of OATP1B Substrates Contributes to Efficient Hepatic Detoxification. Clinical Pharmacology & Therapeutics. 92(5). 559–562. 33 indexed citations
7.
Lagas, Jurjen S., Carola W.N. Damen, Robert A.B. van Waterschoot, et al.. (2012). P-Glycoprotein, Multidrug-Resistance Associated Protein 2, Cyp3a, and Carboxylesterase Affect the Oral Availability and Metabolism of Vinorelbine. Molecular Pharmacology. 82(4). 636–644. 25 indexed citations
8.
Iusuf, Dilek, Rolf W. Sparidans, Anita van Esch, et al.. (2012). Organic Anion-Transporting Polypeptides 1a/1b Control the Hepatic Uptake of Pravastatin in Mice. Molecular Pharmaceutics. 9(9). 2497–2504. 24 indexed citations
9.
Poller, Birk, Dilek Iusuf, Rolf W. Sparidans, et al.. (2011). Differential Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) on Axitinib Brain Accumulation and Oral Plasma Pharmacokinetics. Drug Metabolism and Disposition. 39(5). 729–735. 58 indexed citations
10.
Iusuf, Dilek, Evita van de Steeg, & Alfred H. Schinkel. (2011). Functions of OATP1A and 1B transporters in vivo: insights from mouse models. Trends in Pharmacological Sciences. 33(2). 100–108. 63 indexed citations
11.
Iusuf, Dilek, Sebastiaan F. Teunissen, Els Wagenaar, et al.. (2011). P-Glycoprotein (ABCB1) Transports the Primary Active Tamoxifen Metabolites Endoxifen and 4-Hydroxytamoxifen and Restricts Their Brain Penetration. Journal of Pharmacology and Experimental Therapeutics. 337(3). 710–717. 66 indexed citations
12.
Sparidans, Rolf W., Dilek Iusuf, Alfred H. Schinkel, Jan H.M. Schellens, & Jos H. Beijnen. (2010). Liquid chromatography-tandem mass spectrometric assay for pravastatin and two isomeric metabolites in mouse plasma and tissue homogenates. Journal of Chromatography B. 878(28). 2751–2759. 13 indexed citations
13.
Sparidans, Rolf W., Dilek Iusuf, Alfred H. Schinkel, Jan H.M. Schellens, & Jos H. Beijnen. (2009). Liquid chromatography-tandem mass spectrometric assay for the light sensitive tyrosine kinase inhibitor axitinib in human plasma. Journal of Chromatography B. 877(32). 4090–4096. 40 indexed citations
14.
Oeseburg, Hisko, Dilek Iusuf, Wiek H. van Gilst, et al.. (2008). Bradykinin protects against endothelial cell senescence. Data Archiving and Networked Services (DANS). 1 indexed citations
15.
Iusuf, Dilek, Robert H. Henning, Wiek H. van Gilst, & Anton J.M. Roks. (2008). Angiotensin-(1–7): Pharmacological properties and pharmacotherapeutic perspectives. European Journal of Pharmacology. 585(2-3). 303–312. 109 indexed citations
16.
Oeseburg, Hisko, Dilek Iusuf, Pim van der Harst, et al.. (2008). Bradykinin Protects Against Oxidative Stress–Induced Endothelial Cell Senescence. Hypertension. 53(2). 417–422. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ji Ha Choi Breakdown of academic impact, for papers by Zhousheng Xiao Breakdown of academic impact, for papers by Naoaki Murao Breakdown of academic impact, for papers by Masayuki Ohbayashi Breakdown of academic impact, for papers by Magdalena Niemira Breakdown of academic impact, for papers by Chengguo Wei Breakdown of academic impact, for papers by Qiong‐Yu Mi Breakdown of academic impact, for papers by Maurice G. Emery Breakdown of academic impact, for papers by Kathleen A. Hopp Breakdown of academic impact, for papers by Joseph Jamieson
Rankless by CCL
2026